Is Adalimumab required for long-term maintenance in rheumatoid arthritis?

Adalimumab is a humanized anti-TNF-α monoclonal antibody that is widely used to treat autoimmune diseases such as rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis and other autoimmune diseases. It blocks tumor necrosis factor (TNF) from binding to receptors, thereby reducing joint inflammation and tissue destruction. It is one of the commonly used biological agents in rheumatoid treatment. It works relatively quickly and can improve joint function and delay disease progression.

Rheumatoid arthritis is a chronic, progressive disease that usually cannot be completely cured, so the use of adalimumab is often a long-term maintenance process. Most patients experience significant improvement in symptoms after initial use, but are prone to relapse after discontinuation of treatment. In order to prevent the disease from rebounding and further damaging the joints, doctors usually recommend continuing to take medication after the disease is well controlled to achieve long-term stable control of the disease.

Whether to discontinue adalimumab depends on the patient's individual circumstances. In some patients who achieve clinical remission or low disease activity, physicians may consider tapering the dose or extending the dosing interval. However, stopping the drug carries the risk of relapse and must be done cautiously and under close monitoring. During the observation period after stopping the drug, close attention should be paid to changes in joint symptoms, inflammatory indicators, and imaging evaluation results.

For most rheumatoid patients, maintenance use of adalimumab is an important strategy to ensure efficacy and quality of life. Patients should undergo regular follow-up visits to monitor drug effects and possible adverse reactions, such as injection site reactions, infection risks, etc. At the same time, combined with other basic treatments (such as methotrexate), regular work and rest, and joint protection measures, it can better delay the progression of the disease, control inflammation, and improve long-term treatment effects.

Reference materials:https://www.drugs.com/